US Patent Issued to Boehringer Ingelheim International on Aug. 19 for "N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases" (German Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,667, issued on Aug. 19, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases" was invented by Christian Andreas Kuttruff (Schemmerhofen, Germany), Cedrickx Godbout (Attenweiler, Germany), Hannes Fiepko Koolman (Biberach, Germany) and Gerald Juergen Roth (Warthausen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to N-methyl, N-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflamma...